Gesa Albers
LightNews LightNews
gesaalbers.bsky.social
Gesa Albers
@gesaalbers.bsky.social
37 followers 92 following 5 posts
Postdoctoral Researcher at The Peter Doherty Institute. PhD from Imperial College London. Interested in #macrophages, #lungs, #immunometabolism and #mucosalimmunology.
Posts Replies Media Videos
Reposted by Gesa Albers
mucosalimmunol.bsky.social
It’s #MucosalMonday and time for another MI Podcast episode, fresh from #ICMI2026. Hear from the poster sessions, and listen to Sing Sing Way @babiesresearch.bsky.social and Petter Brodin discuss the immune system during infancy.
www.iheart.com/podcast/269-...
July 27, 2026 at 12:52 PM
Reposted by Gesa Albers
mucosalimmunol.bsky.social
Trainees featured during the poster session include: Gesa Albers @gesaalbers.bsky.social, Mora Massaro @moramassaro.bsky.social, and Nincy Debeuf.
July 27, 2026 at 1:11 PM
Reposted by Gesa Albers
regisjoulia.bsky.social
🔬 PhD position at Imperial College London!
Uncover how pericytes, mysterious vascular cells, drive asthma inflammation. Use spatial transcriptomics, 3D imaging & transgenic models to unlock new therapies.
3-year funded PhD | Oct 2026 start
👉 www.findaphd.com/phds/project...
📧[email protected]
Defining the Immune Functions of Lung Pericytes and Their Dysregulation in Asthma at Imperial College London on FindAPhD.com
PhD Project - Defining the Immune Functions of Lung Pericytes and Their Dysregulation in Asthma at Imperial College London, listed on FindAPhD.com
www.findaphd.com
May 15, 2026 at 1:32 PM
gesaalbers.bsky.social
So proud of @pat-ogger.bsky.social and this next chapter. Huge congratulations, friend ✨
pat-ogger.bsky.social Patricia Ogger @pat-ogger.bsky.social · Jan 5
In my new position as Project Leader at the @mpibiochem.bsky.social I will investigate #macrophage metabolite signaling dynamics. #Immunometabolism
January 27, 2026 at 8:06 AM
gesaalbers.bsky.social
So proud of my best friend for publishing her PhD paper ✨
Huge work, well deserved - check it out!
January 27, 2026 at 7:58 AM
gesaalbers.bsky.social
Check out our paper on the role of itaconate during allergic airway disease 👇🏻
allergy-eaaci.bsky.social Allergy EAACI @allergy-eaaci.bsky.social · Dec 15
Open Access: Protective Role for Itaconate During Inhaled Allergen Challenge. First author: Gesa J. Albers; corresponding author: Adam J. Byrne

👉 doi.org/10.1111/all.70107

Read more articles published in #Allergy on #asthma here: journalallergy.com/Asthma-Lower-Airways

#Allergy_journal
Itaconate levels decrease in sputum following allergen inhalation in mild asthmatics, suggesting a dynamic metabolic response to airway challenge. Genetic deletion of Acod1 in mice did not alter airway inflammation or remodelling in response to chronic house dust mite (HDM) exposure. Inhaled itaconate treatment reduced airway inflammation in HDM-exposed mice, highlighting its potential as a therapeutic strategy for allergic airway disease.
December 15, 2025 at 5:30 PM
gesaalbers.bsky.social
I’m so excited to share that my paper on the role of itaconate in allergic airway disease and asthma has just been published in @allergy-eaaci.bsky.social!

You can read the paper here: onlinelibrary.wiley.com/doi/10.1111/...

#itaconate #allergy #asthma #immunometabolism #innateimmunity
October 25, 2025 at 8:13 AM